AMENDED AND RESTATED ASSET PURCHASE AGREEMENTAsset Purchase Agreement • February 24th, 2021 • Kura Oncology, Inc. • Pharmaceutical preparations • California
Contract Type FiledFebruary 24th, 2021 Company Industry JurisdictionThis Amended And Restated Asset Purchase Agreement (the “Agreement”) is entered into as of February 12, 2015 (“Signing Date”), by and between Kura Oncology, Inc., a Delaware corporation (“Purchaser”), and Araxes Pharma LLC, a Delaware limited liability company (“Seller”). The foregoing may be referred to individually as a “Party” and collectively as “Parties” in this Agreement.
AMENDED AND RESTATED ASSET PURCHASE AGREEMENTAsset Purchase Agreement • March 12th, 2015 • Kura Oncology, Inc. • Blank checks • California
Contract Type FiledMarch 12th, 2015 Company Industry JurisdictionTHIS AMENDED AND RESTATED ASSET PURCHASE AGREEMENT (the “Agreement”) is entered into as of February 12, 2015 (“Signing Date”), by and between KURA ONCOLOGY, INC., a Delaware corporation (“Purchaser”), and ARAXES PHARMA LLC, a Delaware limited liability company (“Seller”). The foregoing may be referred to individually as a “Party” and collectively as “Parties” in this Agreement.